Kerry Preliminary Results Presentation

Similar documents
Kerry Preliminary Results Presentation

Kerry Preliminary Results Presentation

Kerry Interim Results Presentation

Financial Highlights - Interim Results

Press Announcement. Kerry Group plc Annual Results 2002

Press Announcement. Kerry Group plc Annual Results 2004

Press Announcement. Interim Report Half Year Ended 30 June 2007

This presentation contains forward looking statements which reflect. management expectations based on currently available data.

Disclaimer: Forward Looking Statements

Kerry Group Annual Report & Accounts 2002

Disclaimer: Forward Looking Statements

Interim Management Report for the half year ended 30 June 2012

Kerry Group Annual Report & Accounts Integrated Solutions for a Global Market

Kerry Group Preliminary Statement of Results for the year ended 31 December 2017

2017 Full Year. Results Presentation. 21 February 2018

Income taxes (excluding non-trading items) (89.2) (89.5)

2012 half year results

2008 Full year results

Preliminary Statement of Results

Full Year Results 2003

FY17 Results. 25 September 2017

ARYZTA AG. FY 2009 Results. 28 September 2009

2010 Half yearly financial report

Glanbia plc CAGE March Siobhan Talbot Group Managing Director

ARYZTA AG. FY 2016 Results. 26 September 2016

2017 Full Year Results Strong financial performance Investing for the future. 26 January 2018

AEGIS GROUP PLC 2008 ANNUAL RESULTS. 19 March 2009

The J. M. Smucker Company

Glanbia plc 2017 Half Year Results Presentation

Aegis Group plc Half Year Results. 27 August 2010

Annual Results 2017: Quality of business improved due to brand investment, international expansion, and product innovation

Deutsche Bank Conference

Forward looking statements

RESULTS FOR THE YEAR ENDED 31 MARCH Copyright Tate & Lyle PLC 2017

Half year results. Delivering better nutrition for every step of life s journey. Wednesday, 17 August Glanbia plc 2013 half year results

RESULTS For the year ended 30 September 2011

ANNUAL FINANCIAL RESULTS FOR THE YEAR ENDED 31 JULY 2017

For personal use only

Full-year results 2018

6 MARCH 2017 FULL YEAR RESULTS

2005 full year results conference call

Investor Briefing August 2014

Strong performance, delivering a record free cash flow Full Year Results 2012

RNS Number:6672Z. IAWS Group PLC. 13 March 2006 IAWS GROUP PLC. Interim Results Announcement

FULL YEAR RESULTS Conference call, February 2002

TABLE OF CONTENTS. Financial Review 71

Aegis Group plc. 17 March 2011

Glanbia plc 2016 Full Year Results Presentation

THE J. M. SMUCKER COMPANY

RPC GROUP PLC 2017 / 18 RESULTS

ARYZTA AG. FY 2015 Results

McCormick & Company, Inc.

Innophos Holdings, Inc. May 2018

ARYZTA AG. FY 2011 Results 26 September 2011

GENERAL MILLS. Fiscal 2018 Fourth Quarter and Full-year Results. June 27, 2018

McCormick & Company, Inc. 2nd Quarter 2017 Financial Results and Outlook June 29, 2017

Financial Results Q4 2012

2010 Full Year Results Conference Call. James Singh Chief Financial Officer

NUPLEX INDUSTRIES LIMITED RESULTS PRESENTATION FOR THE YEAR ENDED 30 JUNE 2012 PRESENTATION AGENDA

CONSOLIDATED PROFIT AND LOSS ACCOUNT - CONSTANT EXCHANGE RATES (unaudited) Fourth Quarter Millions constant Full Year % Incr./ (Decr.

ANNOUNCEMENT OF PRELIMINARY RESULTS

Full-year results 2017 Conference. February 15, 2018 Nestlé full-year results 2017

2018 Half Year Report Strong recovery in high growth markets

Creating Value While Feeding the World

Treatt plc Interim Results

TREATT PLC PRELIMINARY STATEMENT FOR THE YEAR ENDED 30 SEPTEMBER 2012

CONSOLIDATED PROFIT AND LOSS ACCOUNT CONSTANT EXCHANGE RATES (unaudited)

2016 RESULTS February 15, Emmanuel Faber, CEO Cécile Cabanis, CFO

2017 Half Year Report Sustained good performance

Annual Results Feike Sijbesma, CEO / Chairman Managing Board Annual General Meeting April Page

HALF YEAR RESULTS 20 AUGUST

Tax strategy Givaudan SA

WHITEWAVE FOODS REPORTS RECORD FOURTH QUARTER AND FULL YEAR 2014 RESULTS CONTINUED STRONG GROWTH EXPECTATIONS FOR 2015

Croda International Plc 2013 Preliminary Results. 25 February 2014

All integration targets achieved entering a new era of profitable growth. Full Year 2010 Results

IFF Q Earnings Conference Call

2011 Annual Results Presentation

Pilgrim s Pride Corporation (NASDAQ: PPC) Pilgrim s Acquires Moy Park September 11, 2017

For personal use only

ARYZTA AG. H1 Results, FY 2013 Fixed Income Investor Presentation 11 March 2013

WHITEWAVE FOODS REPORTS RECORD FIRST QUARTER 2015 RESULTS AND INCREASES GROWTH & EARNINGS EXPECTATIONS FOR 2015

Investor Presentation Q Results. 9 May 2018

INVESTOR BRIEFING. March 2013

ARYZTA AG. H1 Results, FY March 2017

Tables reconciling these measures to the UK GAAP measures included in our Financial Statements are shown hereafter.

Year-end results. 18 May

Quarter ended 30 September Financial results & business update

2010 Half yearly results. 25 August 2010

Interim Results 2019 March 2019

Interim Report and Accounts

IFF & Frutarom Creating a Global Leader in Taste, Scent & Nutrition. May 7, 2018

General Mills. Fiscal rd Quarter Results. March 19,

DSM Investor Event 2017

McCormick & Company, Inc. 1 st Quarter 2018 Financial Results and Outlook

CONSOLIDATED PROFIT AND LOSS ACCOUNT - CONSTANT EXCHANGE RATES (unaudited) Fourth Quarter US $ Millions constant Full Year % Incr./ (Decr.

Glanbia delivers sixth consecutive year of double digit earnings growth

GENERAL MILLS. Fiscal 2018 Second Quarter Results. December 20, 2017

GENERAL MILLS FISCAL 2019 SECOND-QUARTER EARNINGS DECEMBER 19, 2018

Strong momentum in Essential Dairy & Plant-Based and Waters offsets Early Life Nutrition contraction in China

GENERAL MILLS REPORTS FISCAL 2019 SECOND-QUARTER RESULTS AND REAFFIRMS FULL-YEAR GUIDANCE

Transcription:

Kerry - 2004 Preliminary Results Presentation Introduction and Overview Hugh Friel Financial Review Brian Mehigan Business Review Hugh Friel Prospects and Future Development Hugh Friel Q&A

Key Accomplishments in 2004 Strong operational and financial performance Continued innovation to meet nutrition, wellness and convenience trends Key acquisitions in fast-growing profitable categories Significant broadening of technical and geographic base Solid platform for continued profitable growth

Financial Highlights Turnover 4.1bn - sales growth of 11.8% Operating profit* growth of 13.1% to 349m Operating margin* up 10bps Earnings per share* up 10.3% to 123.7 cent 2004 dividend per share up 10.7% to 14 cent Record free cash flow of 267m Note: * before goodwill and exceptional items

Performance Overview Ingredients 16% growth Strong market development in key nutritional, convenience food and beverage growth categories Foods brands - good market share growth 111m R&D expenditure 712m investment in expanding technological and market leadership positions Successful establishment of Kerry Bio-Science Strategic investments in flavour, fragrance, natural foods and flavoured beverage sectors

Consumer Challenge Positive stimulus for change and growth Awareness of key food and nutrition values Protein key to innovation and wellness Managed carb-solutions Indulgence - growth niches Convenience Food safety - Kerry s technical platform

Turnover : Like-for-like % Growth 2004 2003 Ingredients 5% 5% Consumer Foods 2% 4% Group 4% 5%

2004 Turnover Growth - by Destination (Total and Like-for-like) 36 30 31% 24 18 12 14% 15% 12% 9% 6 3% 6% 4% 0 Europe Americas Asia Pacific Group Total Like-for-like

Turnover by Destination : Like-for-like % Growth 2001 2002 2003 2004 Europe 3% 6% 4% 3% Americas 9% 6% 5% 6% Asia Pacific 3% 2% 18% 15% Group 5% 6% 5% 4%

EPS* Growth (cent) 140 120 112.1 123.7 100 101.8 87.9 80 79.2 68.0 60 57.4 46.7 40 28.9 35.8 38.7 20 0 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 Note: * before goodwill and exceptional items

Financial Review

2004 Financial Highlights Turnover 4,129m +11.8% +4.2% like-for-like Operating profit* 349m +13.1% +6.6% like-for-like EPS* 123.7 cent +10.3% Free cash flow 267m 2003: 204m Acquisition programme 712m 2003: 208m Note: * before goodwill and exceptional items

Currency Exposure Management Reporting currency translation impact 11% depreciation Dollar v Euro 1% improvement Sterling v Euro Impact (2%) on turnover Impact (3%) at operating profit Impact (2%) at earnings level Trading currency transaction impact on operating profit Rate differential costing 44m across the last two years Balance sheet - assets and liabilities substantially matched

Turnover Analysis 2003 2004 3,693m 4,129m +12% FX Translation -2% Like-for-like +4% Acquisition/Disposal +10%

Turnover : Like-for-like % Growth 2004 Reported Acquisition / Reporting Like-for-like Growth Disposal Currency Growth Ingredients 16% 14% (3%) 5% Consumer Foods 3% 0% 1% 2% Group 12% 10% (2%) 4%

Turnover Growth Like-for-like % Growth Like-for-like % Growth 6 5 4 3 2 1 4% 5% 2004 2003 Volume 4% 5% Price 1% 1% Trading currency (1%) (1%) 0 2004 2003 Group 4% 5%

Operating Margin* Change Operating margin* 8.4% 8.5% Like-for-like growth +20bps Acquisitions / disposals (10bps) Reporting currency 0bps Operating margin* change +10bps Note: * before goodwill and exceptional items

Operating Profit* : Like-for-like % Growth 2004 Reported Acquisition / Reporting Like-for-like Growth Disposal Currency Growth Ingredients 17% 13% (5%) 9% Consumer Foods 2% 0% 1% 1% Group 13% 9% (3%) 7% Like-for-like growth impacted by trading currency transactions at a cost of 20m (2003: 24m) Note: * before goodwill and exceptional items

Five Year Free Cash Flow 2000 2001 2002 2003 2004 m m m m m EBITDA* 296 331 390 392 442 Movement in working capital 13 (34) 46 8 40 Capital expenditure (net) (96) (89) (92) (93) (91) Interest (48) (46) (50) (41) (46) Taxation (42) (44) (43) (40) (54) Dividends (14) (17) (19) (22) (24) Free Cash Flow 109 101 232 204 267 Note: * before exceptional items

Financial Ratios 2004 2003 Debt : Equity 71% 52% Debt : Market capitalisation 35% 27% EBITDA* : Net interest 9.0x 10.5x Debt : EBITDA* 2.6x 1.9x Note: * before exceptional items

Return on Investment 2004 2003 2002 2001 ROAE 14.9% 15.2% 15.2% 14.8% ROACE 11.2% 11.4% 11.6% 11.8% CFROI 13.5% 12.5% 14.6% 9.6%

Other Financial Matters Pension Pension charge increased by 8.0m due to acquisitions and funding of the deficit of 142m Taxation Tax charge on continuing operations up from 28% to 30% Finance charges Up 12m year-on-year due to impact of acquisitions (rate increases offset by strong cash flow) Financing Maturity profile of debt lengthened with the arrangement of a new 500m term debt facility with relationship banks

Exceptional Items 2004 Quest Food Ingredients integration US SBU restructuring (17 acquisitions) Flavours acquisition integration (11 acquisitions) Standardisation of information systems m Total Cost 41.1 Less - Profit on disposal of fixed assets (15.6) Current tax on exceptional items (3.1) Deferred tax on exceptional items (6.9) Net exceptional charge 15.5 Cash spent to date 16.8m - offset by cash from the disposal of assets / tax

International Financial Reporting Standards Effective for all accounting periods commencing from 1 January 2005 Key impact areas for Kerry Goodwill amortisation Pensions Financial instruments Deferred taxation Dividends No cash effect A reconciliation between current GAAP and IFRS will be issued in May 2005

Business Review

Multi-dimensional Ingredients Supply Model Primary Ingredients e.g. Flavour Enzymes Cultures Hydrocolloids Emulsifiers Proteins Yeast extract Primary Raw Materials e.g. Dairy Flour Fruit Soya Spices Sugar Application Specific Ingredients e.g. - Savoury Ingredients - Sweet Ingredients - Nutrition / Protein Food & Beverage Manufacturers Pharmaceutical Health Care Companies Foodservice Suppliers

Kerry Today: Ingredients and Foods Positioning Ingredients ASI s - sweet, savoury, nutritional food and beverage - processor and foodservice applications Flavours Beverage, savoury, sweet, topnote flavours fragrance - niche categories Bio-Science Key bio-ingredients and pharma technologies Linking food and pharma Foods Chilled convenience - leading brands Customer brands - growth categories

Business Review - Ingredients 2004 Total Growth Like-for-like Turnover 2,781m 377m 121m Operating profit 257m 38m 20m Strong market and technical development Good innovation pipeline Consumer dynamics driving growth Kerry business model - forefront of change Emerging markets - optimistic outlook Industry consolidation

Business Review - Ingredients Europe Europe 2004 Total Growth Like-for-like Turnover* 1,165m +18% +4% Excellent growth and development Strong growth in culinary and prepared meal applications Dairy proteins and bio-ingredients Kerry Bio-Science launched 1 May Solid performance in Mastertaste flavours Encouraging market development in Eastern Europe Note: * turnover by location of customers

Business Review - Ingredients Americas Americas 2004 Total Growth Like-for-like Turnover* 1,121m +14% +6% Strong like-for-like growth Good performance in sweet and savoury flavours and ingredients Specialty - challenging environment Excellent growth in foodservice and speciality beverages Bio-Science building strong food and pharma platforms Manheimer - significant flavour and fragrance acquisition Note: * turnover by location of customers

Business Review - Ingredients Asia Pacific Asia Pacific 2004 Total Growth Like-for-like Turnover* 287m +31% +15% Excellent performance across all businesses Major population centres - strong double digit market growth Savoury, flavoured beverages, nutrition, categories - major opportunities Quick-serve restaurants, speciality foodservice expansion Investment in China and Malaysia Note: * turnover by location of customers

Business Review - Consumer Foods 2004 Total Growth Like-for-like Turnover 1,661m + 53m + 30m Operating profit 116m + 2m + 1m Ireland and UK focus Kerry brands outperforming market growth rates Growth in convenience, food-to-go, meal solutions categories Cheese snacking double digit growth Poultry sector challenging environment Poole pastry production Brand development and innovation in added-value growth sectors

2004 Free Cash Flow ( m) 300 267 250 232 200 204 150 100 103 109 101 50 0 1999 2000 2001 2002 2003 2004

Capital Expenditure ( m) 120 114 100 92 101 94 95 89 98 87 96 80 65 74 60 57 40 20 0 1999 2000 2001 2002 2003 2004 Capex Depreciation

R&D Expenditure 120 110 2.7%* 100 90 2.4%* 111m 80 2.1%* 70 60 50 40 30 2.0%* 52m 2.0%* 59m 78m 88m 20 10 0 2000 2001 2002 2003 2004 Note: * figures relate to R&D as a percentage of turnover

Significant Acquisitions 2004 Quest Food Ingredients Manheimer Flavours and Fragrances Flavurence Fructamine Oregon Chai Extreme Foods Jana s Classics Ernsts Food Ingredients Cremo Total Cost 712m

Kerry Bio-Science - Portfolio Analysis Ingredients Dairy Beverage Bakery Culinary Snacks Confection Pharma Emulsifiers Proteins Hydrocolloids Fermented Ingredients Enzymes Yeast products

Strategy Summary Global leadership in ASI s, bio-ingredients, proteins, flavours and pharma ingredients Global partnerships with food processors and food / speciality beverage foodservice providers Growth in emerging markets - nutrition focus Build on Kerry Bio-Science pharma platform Leadership in chilled foods dynamic growth categories (Ireland and UK) Investment in strong brands with leading market positions

Prospects Strong portfolio of technologies and brands Significant growth opportunities in core business areas Strong business management capability and track record Complementary acquisitions Good start to 2005 Earnings outlook for year in line with market expectations

Additional Information

EPS Broker Estimates - Full Year 2005 2005 EPS % Cent Growth Consensus 131.5 6.3 Davy 132.0 6.7 SSSB 130.8 5.7 ABN Amro 128.5 3.9 Goodbody 133.1 7.6 Merrion 134.1 8.4 NCB 129.9 5.0 Cazenove 131.9 6.6

Analysis of Results by Business 2004 2003 Operating Operating Turnover Profit* % Turnover Profit* % m m m m Ingredients 2,781 257 9.2% 2,403 218 9.1% Consumer Foods 1,661 116 7.0% 1,608 114 7.1% Elimination / Unallocated (313) (24) (318) (23) Group 4,129 349 8.5% 3,693 309 8.4% Note: * before goodwill and exceptional items

2004 Analysis of Results by Business 2004 2004 Turnover Operating Profit Like-for-like Like-for-like m Growth m Growth Ingredients 2,781 5% 257 9% Consumer Foods 1,661 2% 116 1% Elimination / Unallocated (313) (24) Group 4,129 4% 349 7%

2003 Analysis of Results by Business 2003 2003 Turnover Operating Profit Like-for-like Like-for-like m Growth m Growth Ingredients 2,403 5% 218 9% Consumer Foods 1,608 4% 114 4% Elimination / Unallocated (318) (23) Group 3,693 5% 309 8%

Operating Margin* Trend 2002 2003 2004 Ingredients 9.0% 9.1% 9.2% Consumer Foods 6.7% 7.1% 7.0% Group 8.1% 8.4% 8.5% Note: * before goodwill and exceptional items

Cash Flow ( m) 2004 2003 Cash from operations 482 400 Interest and taxation (100) (81) Capital expenditure (91) (93) Equity dividends (24) (22) Free cash flow 267 204 Acquisitions and disposals - Businesses acquired (727) (212) - Businesses sold - 1 - Acquisitions restructuring (17) (17) (744) (228) Financing - issue of share capital 10 2 (467) (22) Exchange adjustment on net debt 35 81 (Decrease) / increase in borrowings (432) 59 Opening net debt (705) (764) Closing net debt (1,137) (705)

Ingredients / Flavours / Bio-Science - Acquisitions 2000 2004 Sweet Nutrition & Protein Savoury & Foodservice Mastertaste Bio-Science 2000 Shade Foods Solnuts 2001 SPI Iowa Soy SPI Siber Nutrir Alferi Creative Demicombe Voyager Aromont Corol San Giorgio Geneva Hickory 2002 Ringger Roskam Ringger IDSA Turtle Lake Stearns & Lehman Thailand Rector IFI St. Louis Flavours Metarom 2003 Guernsey Bel Pacific Seasonings Da Vinci Gourmet SunPure Crystals International 2004 Cereal Innovations Dale Country Foods Jana s Classics Quest Ingredients Cremo Oregon Chai Extreme Foods Agrinove Tensa Ernsts Food Ingredients Manheimer Flavurence Fructamine Krauss Quest Ingredients

Kerry Foods Acquisitions Since 2000 Convenience Savoury Cheese & Ready Foodservice Direct Snacking Products Spreads Meals Sales Golden Vale Platters Deli Products Northern Foods (Van Distribution) Freshways Hibernia / Diversity

Debt Profile ( m) Net @ Floating @ Fixed Borrowings Rates Rates Euro 381 381 - Sterling 95 95 - US Dollar 576 116 460 Others 85 85-1,137 677 460 60% 40% Weighted average period for which rate is fixed: 1.2 years

Maturity Profile of Net Debt 31 Dec 2004 31 Dec 2003 m m Within one year (1) (39) Between 1 and 2 years 176 142 Between 2 and 5 years 432 31 Between 5 and 10 years 294 321 After 10 years 236 250 1,137 705 Weighted average maturity in years: 5.4 7.8

Historical Debt Equity Ratio % 1986-2004 140 133 120 121 100 95 80 60 40 55 43 57 39 56 47 56 73 61 79 68 52 70 63 52 71 20 0 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004

EBITDA* / Net Interest 12 10 9.0x 8 6 4 2 0 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 Note: * before exceptional items

Net Debt / EBITDA* 6 5 4 3 2 2.6x 1 0 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 Note: * before exceptional items

EPS Reconciliation 2003 2004 Growth cent cent % 112.1 EPS* 123.7 10.3% (25.9) Goodwill amortisation (37.2) 0.5 Exceptional items (net of tax) (8.3) 86.7 FRS3 EPS 78.2 (9.8%) Note: * before goodwill and exceptional items

Shareholder Analysis Foreign Ownership 29% Irish Ownership 71% North American Institutions 19% UK Institutions 6% Continental Europe / Rest of World Institutions 4% Kerry Co-op 31% Irish Individuals 24% Irish Institutions 16% Shares in issue: 187 million 31 December 2004